Gerard J Criner Selected Research

fluticasone furoate

1/2023	Mortality Risk and Serious Cardiopulmonary Events in Moderate-to-Severe COPD: Post Hoc Analysis of the IMPACT Trial.
12/2022	Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: Post hoc analysis of the IMPACT trial.
12/2022	Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis.
1/2022	Higher COPD Assessment Test Score Associated With Greater Exacerbations Risk: A Post Hoc Analysis of the IMPACT Trial.
1/2022	Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial.
6/2021	Triple Versus Dual Combination Therapy in Chronic Obstructive Pulmonary Disease in Asian Countries: Analysis of the IMPACT Trial.
4/2021	InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations.
1/2021	Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD: A Post Hoc Analysis of the Informing the Pathway of COPD Treatment Trial.
1/2021	Risk of Exacerbation and Pneumonia with Single-Inhaler Triple versus Dual Therapy in IMPACT.
1/2021	Prognostic value of clinically important deterioration in COPD: IMPACT trial analysis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gerard J Criner Research Topics

Disease

180	Chronic Obstructive Pulmonary Disease (COPD) 02/2024 - 01/2004
61	Emphysema 04/2024 - 01/2002
19	Dyspnea (Shortness of Breath) 01/2023 - 10/2004
14	Inflammation (Inflammations) 12/2023 - 01/2007
14	Respiratory Insufficiency (Respiratory Failure) 01/2023 - 12/2002
13	COVID-19 10/2023 - 01/2020
13	Pneumonia (Pneumonitis) 10/2023 - 01/2006
9	Idiopathic Pulmonary Fibrosis 04/2024 - 10/2017
7	Pulmonary Hypertension 03/2024 - 01/2003
7	Lung Diseases (Lung Disease) 03/2024 - 01/2017
7	Disease Progression 07/2023 - 09/2013
6	Chronic Bronchitis 01/2023 - 12/2013
6	Hypoxia (Hypoxemia) 01/2022 - 01/2013
6	Pneumothorax 01/2021 - 08/2009
5	Asthma (Bronchial Asthma) 02/2024 - 06/2009
5	Sarcoidosis (Schaumann Disease) 07/2023 - 10/2019
4	Infections 01/2022 - 03/2015
4	Mitochondrial Diseases (Mitochondrial Disease) 04/2021 - 08/2019
3	Airway Obstruction (Choking) 12/2023 - 01/2019
3	Cystic Fibrosis (Mucoviscidosis) 12/2023 - 01/2013
3	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2023 - 01/2019
3	Cough 01/2023 - 12/2013
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 12/2012
3	Neoplasms (Cancer) 01/2022 - 11/2021
3	Weight Loss (Weight Reduction) 12/2021 - 03/2015
3	Nausea 01/2020 - 01/2017
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2019 - 01/2017
2	Pulmonary Arterial Hypertension 03/2024 - 11/2006
2	Genetic Predisposition to Disease (Genetic Predisposition) 12/2023 - 01/2007
2	Coronary Artery Disease (Coronary Atherosclerosis) 11/2023 - 01/2023
2	Primary Graft Dysfunction 01/2023 - 11/2022
2	Pulmonary Emphysema 10/2022 - 08/2019
2	Virus Diseases (Viral Diseases) 01/2022 - 03/2015
2	Wounds and Injuries (Trauma) 01/2022 - 08/2009
2	Sepsis (Septicemia) 01/2022 - 04/2004
2	Body Weight (Weight, Body) 11/2021 - 01/2021
2	Necrosis 11/2021 - 01/2014

Drug/Important Bio-Agent (IBA)

34	GoldIBA 07/2023 - 12/2008
24	Oxygen (Dioxygen)IBA 03/2023 - 01/2003
16	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2022 - 04/2007
15	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2007
15	GSK573719IBA 01/2023 - 05/2018
15	vilanterolIBA 01/2023 - 05/2018
15	fluticasone furoate FDA Link 01/2023 - 05/2018
15	Bronchodilator Agents (Bronchodilators)IBA 01/2023 - 04/2007
15	Azithromycin (Zithromax)FDA LinkGeneric 07/2022 - 08/2011
12	SmokeIBA 12/2023 - 01/2004
9	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 06/2014
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2009
7	Simvastatin (Zocor)FDA LinkGeneric 07/2022 - 01/2014
7	MacrolidesIBA 12/2021 - 03/2014
5	Monoclonal AntibodiesIBA 10/2023 - 10/2017
5	Immunoglobulin G (IgG)IBA 10/2020 - 09/2009
4	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 12/2023 - 01/2022
4	Fibrinogen (Factor I)FDA Link 01/2023 - 01/2016
4	C-Reactive ProteinIBA 01/2023 - 01/2016
4	Formoterol Fumarate (Oxis)FDA Link 04/2021 - 01/2007
4	Tiotropium Bromide (Spiriva)FDA Link 04/2021 - 02/2008
4	SteroidsIBA 01/2021 - 01/2017
4	Muscarinic AntagonistsIBA 01/2020 - 01/2017
3	Vasodilator Agents (Vasodilators)IBA 03/2024 - 05/2008
3	Metoprolol (Toprol-XL)FDA LinkGeneric 11/2023 - 01/2016
3	Ferritins (Ferritin)IBA 01/2023 - 01/2020
3	benralizumabIBA 01/2023 - 12/2019
3	nintedanibIBA 01/2023 - 01/2017
3	CytokinesIBA 01/2022 - 10/2020
3	Mitochondrial DNA (mtDNA)IBA 04/2021 - 08/2019
3	Carbon DioxideIBA 10/2020 - 05/2009
3	GlucocorticoidsIBA 05/2018 - 06/2014
2	Intravenous Immunoglobulins (IVIG)FDA Link 03/2024 - 02/2024
2	Rituximab (Mabthera)FDA Link 03/2024 - 02/2024
2	CalciumIBA 11/2023 - 10/2019
2	CreatinineIBA 01/2023 - 01/2020
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023 - 01/2022
2	pirfenidoneIBA 01/2023 - 01/2017
2	Angiotensin Receptor AntagonistsIBA 10/2022 - 10/2021
2	Losartan (Cozaar)FDA LinkGeneric 10/2022 - 10/2021
2	GasesIBA 01/2022 - 10/2004
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2022 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2018
2	InterferonsIBA 01/2022 - 01/2021
2	Interleukin-33IBA 12/2021 - 03/2015
2	Budesonide (Pulmicort)FDA LinkGeneric 04/2021 - 01/2021
2	NAD (NADH)IBA 04/2021 - 01/2020
2	Interleukin-8 (Interleukin 8)IBA 01/2021 - 09/2015
2	RoflumilastIBA 01/2021 - 12/2018

Therapy/Procedure

89	Therapeutics 03/2024 - 11/2005
47	Pneumonectomy (Lung Volume Reduction) 04/2024 - 01/2002
18	Lung Transplantation 02/2024 - 01/2002
16	Nebulizers and Vaporizers (Inhaler) 01/2023 - 01/2017
14	Artificial Respiration (Mechanical Ventilation) 02/2024 - 12/2002
10	Noninvasive Ventilation 02/2024 - 05/2014
7	Transplantation 01/2023 - 01/2004
4	Mechanical Ventilators (Ventilator) 01/2023 - 01/2006
4	Patient Readmission 12/2018 - 01/2015
3	Extracorporeal Membrane Oxygenation 02/2024 - 06/2020
3	Length of Stay 01/2023 - 02/2011
2	Plasma Exchange 03/2024 - 02/2024
2	Critical Care (Surgical Intensive Care) 02/2024 - 01/2015
2	Activities of Daily Living (ADL) 01/2022 - 01/2018